OM Pharma SA
- Address
- Rue Du Bois-Du-Lan 22
Sponsor Overview
Specializations
Paediatric respiratory infections
OM Pharma SA’s clinical research includes recurrent respiratory tract infections in young children, with attention to wheezing lower respiratory illness and infection-related respiratory morbidity.
- Recurrent respiratory tract infections
- Wheezing lower respiratory illness
- Paediatric respiratory disease
The sponsor’s studies in this area focus on childhood respiratory conditions where infection and wheezing overlap clinically.
Recurrent wheezing
Another key area of interest is recurrent wheezing in infants and young children, reflecting a focus on early-life respiratory symptoms and their persistence over time.
- Recurrent wheezing
- Infant respiratory symptoms
- Childhood airway reactivity
Research activity in this domain addresses repeated wheezing episodes in a paediatric population with ongoing respiratory vulnerability.
Allergic asthma
The sponsor also funds work in mild allergic asthma, indicating interest in inflammatory airway disease and allergy-associated respiratory impairment.
- Mild allergic asthma
- Allergic airway inflammation
- Asthma in healthy volunteers and patients
This area links respiratory allergy with clinical evaluation of tolerability and safety in people affected by mild asthma.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety of OM-85 in Pediatric Patients with Recurrent Wheezing: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial |  Hungary Poland | Not Recruiting |
| Efficacy of OM-85 in Preventing Recurrent Respiratory Tract Infections with Wheezing in Children Aged 6 Months to 5 Years: A Randomized, Double-Blind, Placebo-Controlled Study |  Germany Hungary Italy Poland | Not Recruiting |
| Safety and Tolerability Assessment of OM-85-IN in Healthy Volunteers and Patients with Mild Allergic Asthma | Germany | Not Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 30 sites across their trial portfolio.
Therapeutic Focus
- 1.Respiratory Tract Diseases3 trials277 other sponsors
Partnered Research Centres
30 centres- Address
- Ul. Polskiego Czerwonego Krzyza 26, 33-100 Tarnow
- Address
- Pck 26 Street, 33-100 Tarnow
- Address
- Arany Janos Utca 14, 6720 Szeged
- Address
- Viale Antonio Gramsci 14, 43126 Parma
- Address
- Via Paradisa 2, 56124 Pisa
- Address
- Rakoczi Fejedelem Ut 125-127, 2660 Balassagyarmat
Want to get in touch with this sponsor?
Send a question and we'll pass it on to OM Pharma SA.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.